| Year |
Citation |
Score |
| 2022 |
Meijboom KE, Sutton ER, McCallion E, McFall E, Anthony D, Edwards B, Kubinski S, Tapken I, Bünermann I, Hazell G, Ahlskog N, Claus P, Davies KE, Kothary R, Wood MJA, et al. Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice. Skeletal Muscle. 12: 18. PMID 35902978 DOI: 10.1186/s13395-022-00301-z |
0.469 |
|
| 2020 |
Lovering RM, Iyer SR, Edwards B, Davies KE. Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neuroscience Letters. 135304. PMID 32818587 DOI: 10.1016/J.Neulet.2020.135304 |
0.518 |
|
| 2020 |
Babbs A, Berg A, Chatzopoulou M, Davies KE, Davies SG, Edwards B, Elsey DJ, Emer E, Figuccia ALA, Fletcher AM, Guiraud S, Harriman S, Moir L, Robinson N, Rowley JA, et al. Synthesis of SMT022357 enantiomers and evaluation in a Duchenne muscular dystrophy mouse model. Tetrahedron. 76: 130819. PMID 32713969 DOI: 10.1016/J.Tet.2019.130819 |
0.45 |
|
| 2020 |
Babbs A, Berg A, Chatzopoulou M, Davies KE, Davies SG, Edwards B, Elsey D, Emer E, Guiraud S, Harriman S, Lecci C, Moir L, Peters D, Robinson N, Rowley J, et al. 2-Arylbenzo[d]oxazole phosphinate esters as second-generation modulators of utrophin for the treatment of Duchenne Muscular Dystrophy. Journal of Medicinal Chemistry. PMID 32551645 DOI: 10.1021/Acs.Jmedchem.0C00807 |
0.467 |
|
| 2019 |
Guiraud S, Edwards B, Babbs A, Squire SE, Berg A, Moir L, Wood MJ, Davies KE. The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy. Human Molecular Genetics. PMID 30990876 DOI: 10.1093/Hmg/Ddz049 |
0.521 |
|
| 2018 |
Guiraud S, Edwards B, Squire SE, Moir L, Berg A, Babbs A, Ramadan N, Wood MJ, Davies KE. Embryonic myosin is a regeneration marker to monitor utrophin based therapies for DMD. Human Molecular Genetics. PMID 30304405 DOI: 10.1093/Hmg/Ddy353 |
0.549 |
|
| 2017 |
Guiraud S, Edwards B, Squire SE, Babbs A, Shah N, Berg A, Chen H, Davies KE. Identification of serum protein biomarkers for utrophin based DMD therapy. Scientific Reports. 7: 43697. PMID 28252048 DOI: 10.1016/J.Nmd.2017.06.269 |
0.492 |
|
| 2015 |
Guiraud S, Squire SE, Edwards B, Chen H, Burns DT, Shah N, Babbs A, Davies SG, Wynne GM, Russell AJ, Elsey D, Wilson FX, Tinsley JM, Davies KE. Second-generation compound for the modulation of utrophin in the therapy of DMD. Human Molecular Genetics. 24: 4212-24. PMID 25935002 DOI: 10.1093/Hmg/Ddv154 |
0.554 |
|
| 2015 |
Liu KX, Edwards B, Lee S, Finelli MJ, Davies B, Davies KE, Oliver PL. Neuron-specific antioxidant OXR1 extends survival of a mouse model of amyotrophic lateral sclerosis. Brain : a Journal of Neurology. 138: 1167-81. PMID 25753484 DOI: 10.1093/Brain/Awv039 |
0.459 |
|
| 2014 |
Paton L, Bitoun E, Kenyon J, Priestman DA, Oliver PL, Edwards B, Platt FM, Davies KE. A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology. The Journal of Biological Chemistry. 289: 26709-21. PMID 25107912 DOI: 10.1074/Jbc.M114.586156 |
0.478 |
|
| 2014 |
Van Rossen E, Liu Z, Blijweert D, Eysackers N, Mannaerts I, Schroyen B, El Taghdouini A, Edwards B, Davies KE, Sokal E, Najimi M, Reynaert H, van Grunsven LA. Syncoilin is an intermediate filament protein in activated hepatic stellate cells. Histochemistry and Cell Biology. 141: 85-99. PMID 24043511 DOI: 10.1007/s00418-013-1142-5 |
0.41 |
|
| 2012 |
Oliver PL, Sobczyk MV, Maywood ES, Edwards B, Lee S, Livieratos A, Oster H, Butler R, Godinho SI, Wulff K, Peirson SN, Fisher SP, Chesham JE, Smith JW, Hastings MH, et al. Disrupted circadian rhythms in a mouse model of schizophrenia. Current Biology : Cb. 22: 314-9. PMID 22264613 DOI: 10.1016/J.Cub.2011.12.051 |
0.436 |
|
| 2011 |
Oliver PL, Finelli MJ, Edwards B, Bitoun E, Butts DL, Becker EB, Cheeseman MT, Davies B, Davies KE. Oxr1 is essential for protection against oxidative stress-induced neurodegeneration. Plos Genetics. 7: e1002338. PMID 22028674 DOI: 10.1371/Journal.Pgen.1002338 |
0.441 |
|
| 2010 |
Clarke WT, Edwards B, McCullagh KJ, Kemp MW, Moorwood C, Sherman DL, Burgess M, Davies KE. Syncoilin modulates peripherin filament networks and is necessary for large-calibre motor neurons. Journal of Cell Science. 123: 2543-52. PMID 20587592 DOI: 10.1242/jcs.059113 |
0.445 |
|
| 2009 |
Kemp MW, Edwards B, Burgess M, Clarke WT, Nicholson G, Parry DA, Davies KE. Syncoilin isoform organization and differential expression in murine striated muscle. Journal of Structural Biology. 165: 196-203. PMID 19070665 DOI: 10.1016/j.jsb.2008.11.002 |
0.446 |
|
| 2008 |
McCullagh KJ, Edwards B, Kemp MW, Giles LC, Burgess M, Davies KE. Analysis of skeletal muscle function in the C57BL6/SV129 syncoilin knockout mouse. Mammalian Genome : Official Journal of the International Mammalian Genome Society. 19: 339-51. PMID 18594912 DOI: 10.1007/s00335-008-9120-2 |
0.491 |
|
| 2007 |
McCullagh KJ, Edwards B, Poon E, Lovering RM, Paulin D, Davies KE. Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscular Disorders : Nmd. 17: 970-9. PMID 17629480 DOI: 10.1016/j.nmd.2007.06.004 |
0.473 |
|
| Show low-probability matches. |